BTIG Reiterates Buy on Haemonetics, Maintains $84 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.2%

Neg 0% Neu 87.2% Pos 0%

BTIG analyst Marie Thibault reiterates Haemonetics (NYSE:HAE) with a Buy and maintains $84 price target.

Comments

No comments yet. Be the first!